UCHL5 and hematologic disorder: We have demonstrated that CuPT and auranofin are the novel metal inhibitors of UCHL5 and USP14 of the 19S proteasome by using several tumor models, including hematological malignancies, several solid tumor models and primary cells of the acute myeloid leukemia patients.